Hacker News
new
|
past
|
comments
|
ask
|
show
|
jobs
|
submit
login
Gatsky
on July 9, 2021
|
parent
|
context
|
favorite
| on:
Death rates are declining for many common cancers ...
None of which are proven in solid tumours. Talimogene laherparepvec, a viral immunotherapy is another one in actual use, but is much less impactful than nivo/pembro/atezolizumab.
Join us for
AI Startup School
this June 16-17 in San Francisco!
Guidelines
|
FAQ
|
Lists
|
API
|
Security
|
Legal
|
Apply to YC
|
Contact
Search: